rs199503269
Variant summary
Our verdict is Pathogenic. Variant got 18 ACMG points: 18P and 0B. PVS1PM2PP5_Very_Strong
The NM_173076.3(ABCA12):c.7444C>T(p.Arg2482Ter) variant causes a stop gained change. The variant allele was found at a frequency of 0.0000155 in 1,613,198 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a pathogenic outcome for this variant. Variant has been reported in ClinVar as Pathogenic (★★). Variant results in nonsense mediated mRNA decay.
Frequency
Genomes: 𝑓 0.000013 ( 0 hom., cov: 33)
Exomes 𝑓: 0.000016 ( 0 hom. )
Consequence
ABCA12
NM_173076.3 stop_gained
NM_173076.3 stop_gained
Scores
5
1
1
Clinical Significance
Conservation
PhyloP100: 4.73
Genes affected
ABCA12 (HGNC:14637): (ATP binding cassette subfamily A member 12) The membrane-associated protein encoded by this gene is a member of the superfamily of ATP-binding cassette (ABC) transporters. ABC proteins transport various molecules across extra- and intracellular membranes. ABC genes are divided into seven distinct subfamilies (ABC1, MDR/TAP, MRP, ALD, OABP, GCN20, and White). This encoded protein is a member of the ABC1 subfamily, which is the only major ABC subfamily found exclusively in multicellular eukaryotes. Alternative splicing of this gene results in multiple transcript variants. [provided by RefSeq, Jul 2008]
Genome browser will be placed here
ACMG classification
Classification made for transcript
Verdict is Pathogenic. Variant got 18 ACMG points.
PVS1
?
Loss of function variant, product undergoes nonsense mediated mRNA decay. LoF is a known mechanism of disease.
PM2
?
Very rare variant in population databases, with high coverage;
PP5
?
Variant 2-214937608-G-A is Pathogenic according to our data. Variant chr2-214937608-G-A is described in ClinVar as [Pathogenic]. Clinvar id is 419453.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr2-214937608-G-A is described in Lovd as [Pathogenic].
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | UniProt |
---|---|---|---|---|---|---|---|
ABCA12 | NM_173076.3 | c.7444C>T | p.Arg2482Ter | stop_gained | 51/53 | ENST00000272895.12 | |
SNHG31 | NR_110292.1 | n.322-10217G>A | intron_variant, non_coding_transcript_variant |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|
ABCA12 | ENST00000272895.12 | c.7444C>T | p.Arg2482Ter | stop_gained | 51/53 | 1 | NM_173076.3 | P1 | |
SNHG31 | ENST00000670391.1 | n.438-24202G>A | intron_variant, non_coding_transcript_variant |
Frequencies
GnomAD3 genomes ? AF: 0.0000132 AC: 2AN: 152084Hom.: 0 Cov.: 33
GnomAD3 genomes
?
AF:
AC:
2
AN:
152084
Hom.:
Cov.:
33
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD3 exomes AF: 0.0000199 AC: 5AN: 250934Hom.: 0 AF XY: 0.0000221 AC XY: 3AN XY: 135604
GnomAD3 exomes
AF:
AC:
5
AN:
250934
Hom.:
AF XY:
AC XY:
3
AN XY:
135604
Gnomad AFR exome
AF:
Gnomad AMR exome
AF:
Gnomad ASJ exome
AF:
Gnomad EAS exome
AF:
Gnomad SAS exome
AF:
Gnomad FIN exome
AF:
Gnomad NFE exome
AF:
Gnomad OTH exome
AF:
GnomAD4 exome AF: 0.0000157 AC: 23AN: 1460996Hom.: 0 Cov.: 30 AF XY: 0.0000165 AC XY: 12AN XY: 726848
GnomAD4 exome
AF:
AC:
23
AN:
1460996
Hom.:
Cov.:
30
AF XY:
AC XY:
12
AN XY:
726848
Gnomad4 AFR exome
AF:
Gnomad4 AMR exome
AF:
Gnomad4 ASJ exome
AF:
Gnomad4 EAS exome
AF:
Gnomad4 SAS exome
AF:
Gnomad4 FIN exome
AF:
Gnomad4 NFE exome
AF:
Gnomad4 OTH exome
AF:
GnomAD4 genome ? AF: 0.0000131 AC: 2AN: 152202Hom.: 0 Cov.: 33 AF XY: 0.00 AC XY: 0AN XY: 74420
GnomAD4 genome
?
AF:
AC:
2
AN:
152202
Hom.:
Cov.:
33
AF XY:
AC XY:
0
AN XY:
74420
Gnomad4 AFR
AF:
Gnomad4 AMR
AF:
Gnomad4 ASJ
AF:
Gnomad4 EAS
AF:
Gnomad4 SAS
AF:
Gnomad4 FIN
AF:
Gnomad4 NFE
AF:
Gnomad4 OTH
AF:
Bravo
AF:
ExAC
?
AF:
AC:
2
EpiCase
AF:
EpiControl
AF:
ClinVar
Significance: Pathogenic
Submissions summary: Pathogenic:5
Revision: criteria provided, multiple submitters, no conflicts
LINK: link
Submissions by phenotype
not provided Pathogenic:2
Pathogenic, criteria provided, single submitter | clinical testing | GeneDx | Jul 05, 2018 | The R2482X pathogenic variant in the ABCA12 gene has been reported previously with another ABCA12 variant in association with harlequin ichthyosis (Akiyama et al., 2007; Koocheck et al., 2014). In one of these patients, immunostaining of a skin biopsy demonstrated complete loss of ABCA12 expression in the epidermis (Akiyama et al., 2007). This variant is predicted to cause loss of normal protein function either through protein truncation or nonsense-mediated mRNA decay. The R2482X variant is observed in 1/9,838 (0.01%) alleles from individuals of Ashkenazi Jewish background in large population cohorts (Lek et al., 2016). We interpret R2482X as a pathogenic variant. - |
Pathogenic, criteria provided, single submitter | clinical testing | Invitae | Oct 15, 2023 | This sequence change creates a premature translational stop signal (p.Arg2482*) in the ABCA12 gene. It is expected to result in an absent or disrupted protein product. Loss-of-function variants in ABCA12 are known to be pathogenic (PMID: 20672373). This variant is present in population databases (rs199503269, gnomAD 0.01%). This premature translational stop signal has been observed in individual(s) with congenital ichthyosis (PMID: 17684380, 28851938, 31168818). ClinVar contains an entry for this variant (Variation ID: 419453). For these reasons, this variant has been classified as Pathogenic. - |
Autosomal recessive congenital ichthyosis 4B Pathogenic:2
Pathogenic, criteria provided, single submitter | clinical testing | Foundation for Research in Genetics and Endocrinology, FRIGE's Institute of Human Genetics | Nov 15, 2022 | A homozygous nonsense variation in exon 51 of the ABCA12 gene that results in a stop codon and premature truncation of the protein at codon 2482 was detected. The observed variation has previously been reported in patients with Herlequin ichthyosis (PMID:17684380). The variant has a minor allele frequency of 0.02% in the 1000 genomes database. The reference region is conserved across species. In summary, the variant meets our criteria to be classified as pathogenic. - |
Pathogenic, criteria provided, single submitter | clinical testing | Equipe Genetique des Anomalies du Developpement, Université de Bourgogne | Aug 05, 2016 | - - |
Lamellar ichthyosis Pathogenic:1
Pathogenic, criteria provided, single submitter | clinical testing | Women's Health and Genetics/Laboratory Corporation of America, LabCorp | Apr 27, 2022 | Variant summary: ABCA12 c.7444C>T (p.Arg2482X) results in a premature termination codon, predicted to cause a truncation of the encoded protein or absence of the protein due to nonsense mediated decay, which are commonly known mechanisms for disease. The variant allele was found at a frequency of 2e-05 in 250934 control chromosomes. c.7444C>T has been reported in the literature as a homozygous or compound heterozygous genotype in multiple individuals affected with features of Lamellar Ichthyosis/Harlequin Ichthyosis (example, Sakai_2009, Khalili_2019, Cho_2017, Kun-Darbois_2016). These data indicate that the variant is very likely to be associated with disease. Three clinical diagnostic laboratories have submitted clinical-significance assessments for this variant to ClinVar after 2014 without evidence for independent evaluation. All laboratories classified the variant as pathogenic/likely pathogenic. Based on the evidence outlined above, the variant was classified as pathogenic. - |
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
BayesDel_addAF
Pathogenic
D
BayesDel_noAF
Pathogenic
Cadd
Pathogenic
Dann
Uncertain
Eigen
Pathogenic
Eigen_PC
Pathogenic
FATHMM_MKL
Pathogenic
D
MutationTaster
Benign
A;A
Vest4
GERP RS
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at